The safety profile of Ivermectin, as with any medication including
ivermectin over the counter, is a critical component in its overall evaluation for both existing and potential new applications. Monitoring adverse reactions and understanding the long-term effects are essential to ensuring that the benefits outweigh the risks. This vigilance is particularly crucial when considering off-label uses, where the drug is applied in scenarios beyond its original approval. Such assessments form the backbone of pharmacovigilance, ensuring patient safety remains at the forefront of healthcare provision.
